OTC · CIK 0001004724
RHEP REGIONAL HEALTH PROPERTIES, INC
Insider trading from SEC Form 4. Last filing May 7, 2026. Close $1.07 on Oct 9, 2026, +13% from the 52-week low and -34% from the high.
REGIONAL HEALTH PROPERTIES, INC (RHEP) has 17 SEC Form 4 filings on file from 11 insiders, the latest filed on May 7, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
4 open-market trades have been scored at RHEP. The newest: Brent Morrison (CEO and President) bought $8,771 of stock on Dec 9, 2025, filed Dec 11, 2025, scored 30 (weak). The largest of the 4 shown: Paul Jason O'sullivan (Senior Vice President) bought $37k on Aug 18, 2025, scored 39 (weak). 2 insiders bought within 14 days of each other around Aug 29, 2025.
RHEP closed at $1.07 on Oct 9, 2026, 13% above its 52-week low and 34% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at REGIONAL HEALTH PROPERTIES, INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Brent Morrison CEO and President buy | $8,771 6,049 shares | +3% | - | |
| 25Weak | Brent Morrison CEO and President buy | $7,618 5,403 shares | +3% | - | |
| 31Weak | Gene E Burleson director buy | $9,950 5,000 shares | - | - | |
| 39Weak | Paul Jason O'sullivan Senior Vice President buy | $37k 20,000 shares | +148% | - |
Transactions
Every row filed, 45 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 5, 2026 | Marlie Davis Chief Financial Officer | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 35,000 | May 7, 2026 |
| May 5, 2026 | Marlie Davis Chief Financial Officer | AGrant or award Employee Stock Option(right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | May 7, 2026 |
| Jan 16, 2026 | Steven J Baileys director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | Gene E Burleson director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | F Scott Kellman director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | Steven L Martin director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | C Christian Winkle director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | Kenneth Wayne Taylor director | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +3,000 | $0.00 | $0 | 3,000 | Feb 9, 2026 |
| Jan 16, 2026 | Brent Morrison CEO and President | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 309,499 | Feb 4, 2026 |
| Jan 16, 2026 | Brent Morrison CEO and President | AGrant or award Employee Stock Optionderivative | +100,000 | $0.00 | $0 | 100,000 | Feb 4, 2026 |
| Dec 9, 2025 | Brent Morrison CEO and President | POpen-market purchase Common Stock | +4,099 | $1.45 | $5,944 | 207,549 | Dec 11, 2025 |
| Dec 11, 2025 | Brent Morrison CEO and President | POpen-market purchase Common Stock | +1,950 | $1.45 | $2,828 | 209,499 | Dec 11, 2025 |
| Dec 4, 2025 | Brent Morrison CEO and President | POpen-market purchase Common Stock | +5,403 | $1.41 | $7,618 | 203,450 | Dec 9, 2025 |
| Aug 29, 2025 | Gene E Burleson director | POpen-market purchase Common Stockindirect: The Burleson Family Foundation | +5,000 | $1.99 | $9,950 | 5,000 | Sep 3, 2025 |
| Aug 18, 2025 | Paul Jason O'sullivan Senior Vice President | POpen-market purchase Common Stockindirect: By IRA | +10,600 | $1.85 | $20k | 24,100 | Aug 22, 2025 |
| Aug 19, 2025 | Paul Jason O'sullivan Senior Vice President | POpen-market purchase Common Stockindirect: By IRA | +5,600 | $1.92 | $11k | 29,700 | Aug 22, 2025 |
| Aug 20, 2025 | Paul Jason O'sullivan Senior Vice President | POpen-market purchase Common Stockindirect: By IRA | +3,800 | $1.80 | $6,840 | 33,500 | Aug 22, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Common Stock | +3,253 | - | - | 3,253 | Aug 21, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Common Stockindirect: By IRA | +22 | - | - | 22 | Aug 21, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Common Stockindirect: Eugene E. Burleson Family Trust; Spouse as Trustee | +13,606 | - | - | 13,606 | Aug 21, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Series D 8% Cumulative Conver. Redeemable Preferred Shares | +2,871 | - | - | 2,871 | Aug 21, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Series D 8% Cumulative Conver. Redeemable Preferred Sharesindirect: By IRA | +20 | - | - | 20 | Aug 21, 2025 |
| Aug 14, 2025 | Gene E Burleson director | AGrant or award Series D 8% Cumulative Conver. Redeemable Preferred Sharesindirect: Eugene E. Burleson Family Trust; Spouse as Trustee | +12,009 | - | - | 12,009 | Aug 21, 2025 |
| Aug 14, 2025 | Mark J Stockslager CFO | AGrant or award Common Stock | +24,484 | - | - | 24,484 | Aug 18, 2025 |
| Aug 14, 2025 | Robert M Thornton Jr EVP - Corporate Strategy | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 100,000 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Common Stock | +124,911 | - | - | 124,911 | Aug 18, 2025 |
| Aug 14, 2025 | Robert M Thornton Jr EVP - Corporate Strategy | AGrant or award Common Stockindirect: See Footnote | +125,663 | - | - | 125,663 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Common Stockindirect: As Trustee, Baileys Grandchildren's Trust FBO Jeremy Baileys | +11,330 | - | - | 11,330 | Aug 18, 2025 |
| Aug 14, 2025 | Mark J Stockslager CFO | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Shares | +21,610 | - | - | 21,610 | Aug 18, 2025 |
| Aug 14, 2025 | Robert M Thornton Jr EVP - Corporate Strategy | AGrant or award Common Stockindirect: By IRA | +1,133 | - | - | 1,133 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Common Stockindirect: As Trustee, Baileys Grandchildren's Trust FBO Alison Brooke Baileys | +11,330 | - | - | 11,330 | Aug 18, 2025 |
| Aug 14, 2025 | Robert M Thornton Jr EVP - Corporate Strategy | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: See Footnote | +110,912 | - | - | 110,912 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Common Stockindirect: By IRA | +40,788 | - | - | 40,788 | Aug 18, 2025 |
| Aug 14, 2025 | Robert M Thornton Jr EVP - Corporate Strategy | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: By IRA | +1,000 | - | - | 1,000 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Common Stockindirect: By Spouse | +362 | - | - | 362 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Shares | +110,248 | - | - | 110,248 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: As Trustee, Baileys Grandchildren's Trust FBO Jeremy Baileys | +10,000 | - | - | 10,000 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: As Trustee, Baileys Grandchildren's Trust FBO Alison Brooke Baileys | +10,000 | - | - | 10,000 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: By IRA | +36,000 | - | - | 36,000 | Aug 18, 2025 |
| Aug 14, 2025 | Steven J Baileys director | AGrant or award Series D 8% Cumulative Conver Redeemable Preferred Sharesindirect: By Spouse | +320 | - | - | 320 | Aug 18, 2025 |
| Jun 20, 2025 | Brent Morrison CEO and President | MOption exercise Common Stock | +24,000 | $3.32 | $80k | 109,047 | Jun 23, 2025 |
| Jun 20, 2025 | Brent Morrison CEO and President | MOption exercise Common Stock | +24,000 | $2.03 | $49k | 133,047 | Jun 23, 2025 |
| Jun 20, 2025 | Brent Morrison CEO and President | AGrant or award Common Stock | +65,000 | $0.00 | $0 | 198,047 | Jun 23, 2025 |
| Jun 20, 2025 | Brent Morrison CEO and President | MOption exercise Employee Stock Option (right to buy)derivative | -24,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
| Jun 20, 2025 | Brent Morrison CEO and President | MOption exercise Employee Stock Option (right to buy)derivative | -24,000 | $0.00 | $0 | 0 | Jun 23, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Steven J Baileysother, director
- Gene E Burlesonother, director
- Marlie DavisChief Financial Officer
- F Scott Kellmandirector
- Steven L Martindirector
- Brent MorrisonCEO and President
- Paul Jason O'sullivanSenior Vice President
- Mark J StockslagerCFO
- Robert M Thornton JrEVP - Corporate Strategy
- Kenneth Wayne Taylordirector
- C Christian Winkledirector
Questions about RHEP
Answered from the filings on this page, as of the latest one.
Are insiders buying RHEP?
No. In the last 90 days no insider at REGIONAL HEALTH PROPERTIES, INC bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade RHEP on the open market?
Brent Morrison (CEO and President) bought $8,771 of RHEP on Dec 9, 2025 and filed the Form 4 on Dec 11, 2025. InsiderTell scored 30 (weak).
How many insiders file Form 4 at REGIONAL HEALTH PROPERTIES, INC?
11 people have filed a Form 4 at REGIONAL HEALTH PROPERTIES, INC, among them Steven J Baileys (director), Gene E Burleson (director), Marlie Davis (Chief Financial Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.